ArticleFrontiers in pharmacology2025

Esculetin inhibits the PI3K/Akt/mTOR pathway and enhances anti-colorectal cancer activity via binding to ENO1.

Jianing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.